Literature DB >> 17927568

Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation.

Perenlei Enkhbaatar1, Aimalohi Esechie, Jianpu Wang, Robert A Cox, Yoshimitsu Nakano, Atsumori Hamahata, Matthias Lange, Lillian D Traber, Donald S Prough, David N Herndon, Daniel L Traber.   

Abstract

Burn and smoke inhalation-related multiple organ dysfunction is associated with a severe fall in the plasma concentration of antithrombin. Therefore the aim of the present study was to test the hypothesis that intravenous administration of recombinant human antithrombin in combination with aerosolized heparin will ameliorate acute lung injury in sheep exposed to cutaneous burn and smoke inhalation. Sheep were prepared operatively for study and, 7 days post-surgery, sheep were given a cutaneous burn (40% of total body surface area, third-degree burn) and insufflated with cotton smoke (48 breaths, <40 degrees C) under halothane anaesthesia. After injury, sheep were placed on a ventilator and resuscitated with Ringer's lactate solution. The animals were divided into three groups: sham group (non-injured and non-treated; n=6), saline group (injured and received saline; n=6) and rhAT.iv.+Hep group [injured and treated with rhAT (recombinant human antithrombin) and heparin; n=6]. In the rhAT.iv.+Hep group, rhAT was infused continuously for 48 h starting 1 h post-injury with a dose of 0.34 mg.h(-1).kg(-1) of body weight and heparin (10000 units) was aerosolized every 4 h starting at 1 h post-injury. The experiment lasted 48 h. Haemodynamics were stable in sham group, whereas the saline-treated sheep developed multiple signs of acute lung injury, including decreased pulmonary gas exchange, increased inspiratory pressures, extensive airway obstruction and increased pulmonary oedema. These pathological changes were associated with a severe fall in plasma antithrombin concentration, lung tissue accumulation of leucocytes and excessive production of NO. Treatment of injured sheep with anticoagulants attenuated all of the pulmonary pathophysiology observed. In conclusion, the results provide definitive evidence that anticoagulant therapy may be a novel and effective treatment tool in the management of burn patients with concomitant smoke inhalation injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17927568     DOI: 10.1042/CS20070254

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  23 in total

Review 1.  [Inhalation injury--epidemiology, diagnosis and therapy].

Authors:  Ulrich Thaler; Paul Kraincuk; Lars-Peter Kamolz; Manfred Frey; Philipp G H Metnitz
Journal:  Wien Klin Wochenschr       Date:  2010-01       Impact factor: 1.704

2.  Nebulization with γ-tocopherol ameliorates acute lung injury after burn and smoke inhalation in the ovine model.

Authors:  Yusuke Yamamoto; Perenlei Enkhbaatar; Linda E Sousse; Hiroyuki Sakurai; Sebastian W Rehberg; Sven Asmussen; Edward R Kraft; Charlotte L Wright; Eva Bartha; Robert A Cox; Hal K Hawkins; Lillian D Traber; Maret G Traber; Csaba Szabo; David N Herndon; Daniel L Traber
Journal:  Shock       Date:  2012-04       Impact factor: 3.454

Review 3.  Anticoagulant therapy in acute respiratory distress syndrome.

Authors:  Marta Camprubí-Rimblas; Neus Tantinyà; Josep Bringué; Raquel Guillamat-Prats; Antonio Artigas
Journal:  Ann Transl Med       Date:  2018-01

Review 4.  Inhalation Injury in the Burned Patient.

Authors:  Guillermo Foncerrada; Derek M Culnan; Karel D Capek; Sagrario González-Trejo; Janos Cambiaso-Daniel; Lee C Woodson; David N Herndon; Celeste C Finnerty; Jong O Lee
Journal:  Ann Plast Surg       Date:  2018-03       Impact factor: 1.539

Review 5.  Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.

Authors:  Andrew C Miller; Elamin M Elamin; Anthony F Suffredini
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

6.  Development of a long-term ovine model of cutaneous burn and smoke inhalation injury and the effects of early excision and skin autografting.

Authors:  Yusuke Yamamoto; Perenlei Enkhbaatar; Hiroyuki Sakurai; Sebastian Rehberg; Sven Asmussen; Hiroshi Ito; Linda E Sousse; Robert A Cox; Donald J Deyo; Lillian D Traber; Maret G Traber; David N Herndon; Daniel L Traber
Journal:  Burns       Date:  2012-03-27       Impact factor: 2.744

Review 7.  [Pathophysiology of acute lung injury in severe burn and smoke inhalation injury].

Authors:  M O Maybauer; S Rehberg; D L Traber; D N Herndon; D M Maybauer
Journal:  Anaesthesist       Date:  2009-08       Impact factor: 1.041

8.  Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury.

Authors:  Perenlei Enkhbaatar; Rhykka Connelly; Jianpu Wang; Yoshimitsu Nakano; Matthias Lange; Atsumori Hamahata; Eszter Horvath; Csaba Szabo; Stefan Jaroch; Peter Hölscher; Margrit Hillmann; Lillian D Traber; Frank C Schmalstieg; David N Herndon; Daniel L Traber
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

9.  Advantages and pitfalls of combining intravenous antithrombin with nebulized heparin and tissue plasminogen activator in acute respiratory distress syndrome.

Authors:  Sebastian Rehberg; Yusuke Yamamoto; Linda E Sousse; Collette Jonkam; Robert A Cox; Donald S Prough; Perenlei Enkhbaatar
Journal:  J Trauma Acute Care Surg       Date:  2014-01       Impact factor: 3.313

10.  Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- and smoke-induced acute lung injury.

Authors:  Aimalohi Esechie; Perenlei Enkhbaatar; Daniel L Traber; Collette Jonkam; Matthias Lange; Atsumori Hamahata; Clarisse Djukom; Elbert B Whorton; Hal K Hawkins; Lillian D Traber; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.